NUVB: Nuvation Bio Inc – Class A Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 389.47
Enterprise Value ($M) 359.40
Book Value ($M) 641.07
Book Value / Share 2.93
Price / Book 0.61
NCAV ($M) 636.58
NCAV / Share 2.91
Price / NCAV 0.61

Profitability (mra)
Return on Invested Capital (ROIC) -0.16
Return on Assets (ROA) -0.14
Return on Equity (ROE) -0.14

Liquidity (mrq)
Quick Ratio 51.99
Current Ratio 51.99

Balance Sheet (mrq) ($M)
Current Assets 652.56
Assets 657.06
Liabilities 15.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -112.33
Net Income -104.20
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -96.11
Cash from Investing 63.46
Cash from Financing 1.33

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Deep Track Capital, LP 3.76 -28.33
02-13 13D/A Omega Fund V, L.P. 6.90 -46.58
02-09 13G/A Vanguard Group Inc 4.55 -11.79
02-09 13G/A Fmr Llc 12.15 -16.23

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-03-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2022-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2022-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-06-07 62,601 683,883 9.15
2023-06-06 45,377 460,972 9.84
2023-06-05 11,623 216,440 5.37
2023-06-02 33,706 383,386 8.79

(click for more detail)

Similar Companies
LLY – Lilly(Eli) & Co MRK – Merck & Co Inc
MYOV – Myovant Sciences Ltd OGN – Organon & Co.
PBH – Prestige Consumer Healthcare Inc


Financial data and stock pages provided by
Fintel.io